Physician profile
Christopher Ferguson
NPI 1679082523
$4,757.42
in general payments reported to CMS, 2019-2025
33 companies · $455 in 2025
The $455 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,116 · 2022: $1,366 · 2023: $790 · 2024: $30.18 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,150 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,149.97 |
| Education | $125.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $1,282.67 | 2021-2022 | |
| Janssen Biotech, INC. | $632.40 | 2021-2025 | Rybrevant, Carvykti, Erleada |
| Abbvie INC. | $413.40 | 2021-2023 | |
| Astellas Pharma US INC | $246.23 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $235.46 | 2021-2023 | Provenge |
| Pfizer INC. | $191.01 | 2021-2023 | |
| Axonics, INC. | $153.60 | 2022 | |
| Urovant Sciences INC | $149.52 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $143.05 | 2021-2023 | Pylarify |
| Rochester Medical Corporation | $126.81 | 2022 | |
| Coloplast Corp | $118.03 | 2021-2023 | Titan |
| Merck Sharp & Dohme LLC | $112.10 | 2021-2023 | Lynparza |
| C. R. Bard, INC. & Subsidiaries | $95.75 | 2023 | Bard Urinary Drainage Bag |
| Bayer Healthcare Pharmaceuticals INC. | $84.66 | 2021-2023 | |
| Hollister Incorporated | $80.99 | 2022-2023 | Vapro Pocket, Infyna Chic, Onli |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $77.45 | 2023-2025 | Jelmyto |
| Boston Scientific Corporation | $73.91 | 2021-2023 | |
| Clarus Therapeutics INC. | $64.38 | 2021 | |
| Antares Pharma, INC. | $61.52 | 2023 | Nocdurna, Tlando, Xyosted |
| 180 Medical, INC. | $59.10 | 2023 | Gentlecath Glide |
| Tolmar Pharmaceuticals, INC. | $49.49 | 2022 | |
| Sumitomo Pharma America, INC. | $47.32 | 2023 | Gemtesa |
| Teleflex LLC | $42.86 | 2021-2023 | Urolift |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Allergan, INC. | $32.28 | 2021 | |
| Viiv Healthcare Company | $30.18 | 2024 | |
| Medtronic, INC. | $27.23 | 2022 | |
| Myriad Genetic Laboratories, INC. | $18.74 | 2021 | |
| Myovant Sciences INC. | $18.39 | 2021 | |
| Dentsply Ih INC. | $17.62 | 2022 | |
| Photocure INC | $14.41 | 2021 | |
| Laborie Medical Technologies Corp. | $12.77 | 2021 | |
| Ambu INC. | $9.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.